Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 7 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2 Pancreatic Neoplasms 1 Nervous System Diseases 1 Metabolic Diseases 1 Breast Neoplasms 1 Aneurysm 1

Interventions

Gemcitabine 205 130-nm albumin-bound paclitaxel 84 Albumin-Bound Paclitaxel 57 pembrolizumab 43 Fluorouracil 41 Leucovorin 34 Oxaliplatin 33 Capecitabine 25 Nivolumab 22 Irinotecan 19 Bevacizumab 17 Paclitaxel 16 Cyclophosphamide 15 Cetuximab 15 Taxes 13 Erlotinib Hydrochloride 13 Drug Therapy 13 Carboplatin 12 irinotecan sucrosofate 11 Injections 10 Cisplatin 9 fludarabine 8 ALT-803 8 spartalizumab 7 olaparib 7 avelumab 7 Pemetrexed 7 Docetaxel 7 ruxolitinib 6 TH 302 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Pancreatic Neoplasms × Magnetic Resonance Imaging × Clear all

NCT05191940 2026-03-20

LAPC

EBG MedAustron GmbH

Phase NA Recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡